Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy

被引：0
作者：
Marie Piroth
Thomas Goronflot
Romain Samaran
Emilie Varey
Alexandra Poinas
Amir Khammari
Brigitte Dreno
机构：
[1] Nantes Université,CHU Nantes Service de Dermatologie, Hôtel
[2] Nantes Université,Dieu, Nantes
[3] Hôpital du Mans,CHU Nantes, Pôle Hospitalo
[4] Nantes Université,Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413
[5] Nantes Université,Service de Dermatologie
来源：
European Journal of Dermatology | 2023年 / 33卷
关键词：
BRAF inhibitor; MEK inhibitor; melanoma; oncology; panniculitis; targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 136
页数：10
相关论文
共 50 条
  • [31] Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
    Svedman, Fernanda Costa
    Das, Ishani
    Tuominen, Rainer
    Ramqvist, Eva Darai
    Hoiom, Veronica
    Brage, Suzanne Egyhazi
    CANCERS, 2022, 14 (15)
  • [32] Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series
    Matteo S Carlino
    Vito Vanella
    Christina Girgis
    Diana Giannarelli
    Alex Guminski
    Lucia Festino
    Richard F Kefford
    Alexander M Menzies
    Georgina V Long
    Paolo A Ascierto
    British Journal of Cancer, 2016, 115 : 1280 - 1284
  • [33] Quantitative changes of melanoma-associated antigens as a biomarker for targeted therapy response
    Arenberger, Petr
    Fialova, Alena
    Gkalpakiotis, Spyridon
    Pavlikova, Andrea
    Arenbergerova, Monika
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (09) : 727 - 729
  • [34] Clinical Nurse Consultant Support Management of patients with melanoma receiving immunotherapy and targeted therapy
    Lomax, Anna J.
    Nielsen, Theresa
    Visintin, Lydia
    O'Carrigan, Brent
    Honeyball, Florian
    Shum, Benjamin
    Saw, Robyn P. M.
    McNeil, Catriona
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (04) : E93 - E98
  • [35] Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma
    Marshall, Julia A.
    Forster, Trevor H.
    Purdie, David M.
    Lanagan, Catherine M.
    O'Connor, Linda E.
    O'Rourke, Michael GE.
    Johnson, Maree K.
    See, Janet L.
    Ellem, Kay AO.
    Martinez, Nathan R.
    Lopez, J. Alejandro.
    Schmidt, Christopher W.
    IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03) : 295 - 302
  • [36] Response to targeted therapy in two patients with metastatic melanoma carrying rare BRAF exon 15 mutations: A598_T599insV and V600_K601delinsE
    Rogiers, Aljosja
    Vander Borght, Sara
    Tuand, Krizia
    Wolter, Pascal
    Stas, Marguerite
    Boecxstaens, Veerle
    Garmyn, Marjan
    van den Oord, Joost J.
    Vandenberghe, Peter
    Bechter, Oliver
    MELANOMA RESEARCH, 2017, 27 (05) : 507 - 510
  • [37] Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma
    Eroglu, Zeynep
    Eatrides, Jennifer
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Youngchul
    Rich, Jeani
    Babacan, Nalan Akgul
    Brohl, Andrew S.
    Markowitz, Joseph
    Sarnaik, Amod
    Zager, Jonathan
    Khushalani, Nikhil I.
    Sondak, Vernon K.
    Messina, Jane
    PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (01) : 86 - 95
  • [38] Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies
    La Greca, Michele
    Grasso, Giuseppe
    Antonelli, Giovanna
    Russo, Alessia Erika
    Bartolotta, Salvatore
    D'Angelo, Alessandro
    Vitale, Felice Vito
    Ferrau, Francesco
    ONCOTARGETS AND THERAPY, 2014, 7 : 1115 - 1121
  • [39] Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma
    Farah, Chantale
    Mignion, Lionel
    Jordan, Benedicte F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [40] Response of an Advanced Lung Cancer Mass to Targeted Therapy
    Schulze, P. A.
    Iglesias, M.
    Menegaz, T.
    Gelatti, A. C.
    Lorandi, V.
    Hochhegger, B.
    Tsukazan, M. T.
    Figueiredo Pinto, J. A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1095 - S1095
12345